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Abstract 
Interrelationships between nuclear architecture and gene expression 
were examined by comparing the representation of nuclear matrix pro- 
teins in ROS 17/2.8 rat and MG-63 human osteosarcoma cells with those 
in normal diploid osteoblasts. The tumor-derived cells coexpress genes 
which are expressed in a sequential and mutually exclusive manner during 
the progressive stages of osteoblast differentiation. In osteosarcoma cells 
two-dimensional electrophoretic analysis indicates a composite represen- 
tation of nuclear matrix proteins characteristic of both the proliferative 
and postproliferative periods of osteoblast phenotype development. In 
addition, nuclear matrix proteins unique to the tumor cells and the ab- 
sence of nuclear matrix proteins found only in normal diploid osteoblasts 
are observed. Tumor-specific nuclear matrix proteins include those ex- 
pressed in a proliferation-dependent and independent manner. There is a 
parallel relationship between nuclear matrix proteins and the expression 
of cell growth and tissue-specific genes during osteoblast differentiation 
and in osteosarcoma cells where the developmental sequence of gene 
expression has been abrogated. Nuclear matrix proteins therefore provide 
markers reflecting defined periods of bone cell differentiation and pheno- 
typic characteristics of an osteosarcoma. 
Introduction 
Transformed and tumor cells exhibit aberrations in the expression 
of cell growth and tissue-specific genes during both the onset and 
progression ofneoplasia. A fundamental rea of investigation is that of 
tumor-related modifications in regulatory parameters that selectively 
restrict or render developmentally expressed genes competent for 
transcription. 
Primary cultures of normal diploid osteoblasts undergo asequential 
expression of cell growth and tissue-specific genes that are function- 
ally related to development of the bone cell phenotype (reviewed in 
Refs. 1, 2-5). This developmental sequence initially includes the 
expression of genes that support cell growth and biosynthesis of the 
type 1 collagen bone extracellular matrix. Expression of genes asso- 
ciated with extracellular matrix maturation, organization, and miner- 
alization are confined to the subsequent postproliferative p riods of 
osteoblast differentiation. I  contrast, osteosarcoma cells such as the 
ROS 17/2.8 line exhibit loss of the developmental sequence of gene 
expression characteristic of normal diploid osteoblasts (6, 7). Abro- 
gation of stringent growth control in these rodent osteosarcoma cells 
is accompanied by and potentially functionally related to concomitant 
expression of genes involved with both proliferation and phenotypic 
properties of mature bone cells. 
The nuclear matrix, the nonchromatin nuclear substructure orga- 
nized as a proteinaceous network of polymorphic anastomosing fibers, 
may contribute to the transcriptional regulation of gene expression 
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during osteoblast differentiation and modifications in the expression 
of cell growth and tissue-specific genes observed in osteosarcoma 
cells. The linkage of nuclear matrix composition tocell and tissue type 
in general is consistent with nuclear matrix participation i the regu- 
lation of gene expression (8, 9-18). Nuclear matrix composition has 
also been shown to be uniquely characteristic of specific tumor cells 
(15, 19-21, 22). Other evidence supporting nuclear matrix involve- 
ment in the regulation of gene expression includes the preferential 
association of actively transcribed genes with the nuclear matrix (23- 
26), the localization of RNA synthesis and pre-mRNA splicing on the 
nuclear matrix (16, 27-33), and the presence of some but not all 
steroid receptors in the nuclear matrix fraction (34-37). 
A role for the nuclear matrix and transcriptional regulation during 
progressive development of the osteoblast phenotype is supported by 
nuclear matrix proteins characteristic of each of the three principal 
periods of osteoblast differentiation (38). More direct evidence for 
nuclear matrix proteins contributing to control of osteoblast differen- 
tiation is provided by developmentally mediated association with the 
nuclear matrix of transcription factors which are cell growth related 
(24), broadly represented (39), and bone specific (40). Proliferation- 
dependent partitioning of oncogene ncoded transcription factors be- 
tween the nuclear matrix and nonmatrix nuclear fraction has been 
observed in osteoblastic cells (39). 
To experimentally address interrelationships between uclear archi- 
tecture and gene expression i  bone tumor cells we compared nuclear 
matrix proteins of normal diploid osteoblasts during differentiation 
with those in ROS 17/2.8 osteosarcoma cells. Consistent with coex- 
pression of genes in osteosarcoma cells which are sequentially and 
independently expressed uring osteoblast differentiation, we ob- 
served a composite representation f nuclear matrix proteins in ROS 
17/2.8 cells which are characteristic of both the proliferative and 
postproliferative p riods of the osteoblast developmental sequence. 
We identified proliferation-dependent and growth-independent 
nuclear matrix proteins that are present in rat as well as human 
osteosarcoma cells but absent in normal diploid osteoblasts. Expres- 
sion of other nuclear matrix proteins is restricted to normal diploid 
bone cells. 
Materials and Methods 
Cell Culture. Primary cultures of normal diploid osteoblasts were obtained 
from the calvaria of timed pregnant rats (Sprague-Dawley). The isolation and 
culture of primary osteoblasts were as described previously (1). Ros 17/2.8 
osteosarcoma cells (41) (generously provided by Drs. Sevgi Rodan and Gideon 
Rodan, Merck Sharp & Dohme, West Point, PA) were grown in F12 media 
supplemented with 5% horse serum. 
Nuclear Matrix Protein Isolation. Cells were pulse-labeled with 25 
ftCi/ml of L-[35S]methionine/ml in methionine-free minimum essential me- 
dium for 2 h at 37~ followed by the isolation of nuclear matrix proteins 
according to the protocol of Fey et al. (8). Two-dimensional gel electrophoresis 
was performed according to the method of O'Farrell (42). 
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Northern Blot Analysis. Extraction of total RNA from cell pellets and 
hybridization conditions with a panel of probes was as detailed elsewhere (43). 
Results and Discussion 
Coexpression of Growth-dependent and Postproliferative Tis- 
sue-specific Genes in Osteosarcoma Cells. It has been well estab- 
lished that differentiation of proliferating, normal diploid osteoblasts 
to postproliferative c lls in a mineralized type 1 collagen extracellular 
matrix is associated with a three-stage developmental sequence of 
gene expression which supports the progressive stablishment of bone 
tissue organization (1). This developmental expression of cell growth 
and tissue-specific genes has been observed in primary cultures of 
normal diploid mammalian osteoblasts during the formation of nod- 
ules of multilayered osteocytic ells in a mineralized extracellular 
matrix with a bone tissue-like organization, as well as during osteo- 
blast differentiation in vivo (reviewed in Refs. 2-5 and 7). First, 
proliferating osteoblasts express genes which support cell cycle and 
cell growth control (e.g., histone, see c-myc, c-Fos and c-Jun) together 
with genes for the initial biosynthesis of the bone extracellular matrix 
(e.g., transforming rowth factor /3, type 1 collagen, fibronectin). 
Equally important is the fact that regulatory mechanisms are operative 
at this time which suppress the expression of genes associated with 
mature osteoblast phenotypic properties. During a second develop- 
mental period immediately following the down-regulation of prolif- 
eration, genes involved with the continued biosynthesis, maturation, 
and organization of the bone extracellular matrix are expressed. Then 
during a third developmental period, gene expression associated with 
competency for the ordered deposition of mineral occurs. 
As indicated in Fig. 1 osteosarcoma cells coexpress genes that are 
sequentially expressed in a strict developmentally dependent manner 
in normal diploid osteoblasts. For example, in rat osteoblasts, a com- 
HISTONE COLLAGEN AP OC OP 
parison of cellular mRNA levels for cell growth and bone tissue- 
related genes during the proliferative and postproliferative period of 
osteoblast differentiation indicates that histone gene expression is 
confined to the initial proliferation period while alkaline phosphatase, 
osteopontin, and osteocalcin expression occur postproliferatively. In 
ROS 17/2.8 osteosarcoma cells, coexpression of cell growth and tis- 
sue-specific genes is strikingly illustrated by high levels of gene 
expression in proliferating cells that occurs in normal diploid cells 
only during the immediate postproliferative period of extracellular 
matrix maturation. Fig. 1 shows that alkaline phosphatase is expressed 
at 80% of maximal evel in proliferating ROS 17/2.8 osteosarcoma 
cells. Also apparent is the lower but significant expression of genes 
associated with the mature normal diploid osteoblast undergoing ex- 
tracellular matrix mineralization (e.g., osteocalcin and osteopontin). 
It therefore appears that in osteosarcoma cells regulatory mecha- 
nisms which support he ordered expression of genes throughout the 
development of the osteoblast phenotype are operative irrespective of 
the level of ongoing proliferation, reflecting an apparent compromise 
of proliferation/differentiation interrelationships. In addition there are 
modifications in regulatory mechanisms that normally are involved 
with changes in gene expression at the developmental transition point 
in mature osteoblasts when the immediate postproliferative genes 
exhibit decreased expression (e.g., alkaline phosphatase) and genes 
associated with the onset of extracellular mineralization are up-regu- 
lated (e.g., osteocalcin and osteopontin). 
Composite Representation of Developmentally Regulated 
Nuclear Matrix Proteins in Osteosarcoma Cells. Support for par- 
ticipation of the nuclear matrix in transcriptional control of osteoblast 
genes is provided by the two-dimensional e ectrophoretic profiles of 
nuclear matrix proteins analyzed throughout the osteoblast develop- 
mental sequence. Changes in the protein composition of the nuclear 
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Fig. 1. Comparison of gene expression in proliferating and postproliferative normal diploid osteoblasts with t ose in osteosarcoma cells. Expression of representative c ll growth 
(histone) and bone related [type 1 collagen, alkaline phosphatase (AP), osteopontin (OP), and osteocalcin (OC)] genes was detected by cellular mRNA levels at day 7 (ROB: 
proliferating) and 27 (ROB: differentiated) in primary cultures of normal diploid, calvarial-derived rat osteoblasts and at days 2 (ROS: proliferating) and 7 (ROS: post-proliferative) 
in ROS 17/2.8 osteosarcoma cell cultures. Analysis of Northern blots was quantitated by microdensitometry, and values are expressed as percentage maximal. These profiles are 
representative of the patterns of gene expression reported for independent cell preparations. 
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Fig. 2. Comparison of the representation f nuclear matrix proteins in normal diploid 
osteoblasts (A), ROS 17/2.8 rat osteosarcoma cells (B), and MG-63 human osteosarcoma 
cells (C). Day 7 (proliferating) and day 27 (postproliferative) normal diploid osteoblasts 
as well as proliferating (day 2) and day 7 (postproliferative) ROS 17/2.8 or MG-63 
osteosarcoma cells were radiolabeled with [35S]methionine. Nuclear matrix-intermediate 
filament proteins were isolated and subjected to two-dimensional electrophoretic analysis. 
Examples of nuclear matrix proteins which are preferentially expressed in differentiated, 
postproliferative normal diploid osteoblasts that are expressed in both proliferating and 
postproliferative osteosarcoma cells are designated 4 and 5. Proteins observed only in 
osteosarcoma cells are designated 1-3, 7, and 8. A protein expressed in normal diploid 
osteoblasts and absent in osteosarcoma cells is designated 6. The representation f des- 
ignated nuclear matrix proteins was verified in at least three independent experiments. 
matrix parallel the sequential expression of genes during the progres- 
sive development of the osteoblast phenotype (38). The composition 
of the nuclear matrix is constant within each of the three principle 
periods of osteoblast differentiation but is modified dramatically at the 
two key transition points: at completion of the proliferation period and 
at the onset of extracellular matrix mineralization. This relationship 
between nuclear matrix protein composition and the expression of 
specific genes is further supported by retention of the characteristic 
stage-specific representation f nuclear matrix proteins when the os- 
teoblast developmental sequence is delayed (38). 
As indicated in Fig. 2 and schematically illustrated in Fig. 3, com- 
parison of proliferating normal diploid osteoblasts (day 7) with post- 
proliferative osteoblasts (day 27) indicates a developmental progres- 
sion of nuclear matrix protein alterations that are similar to those we 
described previously (38). Particularly evident is the increased ex- 
pression of proteins designated 4 and 5 in postproliferative osteoblasts 
during the extracellular matrix maturation and mineralization stages of 
differentiation (Figs. 24 and 3A). Here we demonstrate hat in striking 
contrast, these proteins are expressed at similar and high levels in both 
proliferating and postproliferative rat (Figs. 2B and 3B) as well as 
human (Figs. 2C and 3C) osteosarcoma cells. 
Tumor-related Nuclear Matrix Proteins Characterize the Os- 
teosarcoma Phenotype. In addition to the coexpression of nuclear 
matrix proteins in osteosarcoma cells that are represented in a mutu- 
ally exclusive developmental manner during osteoblast differentia- 
tion, other nuclear matrix proteins are unique to normal diploid os- 
teoblasts and osteosarcoma cells. A predominantly represented Mr 
40,000 nuclear matrix protein (designated 6) is expressed only in 
osteoblasts and not in rat (ROS 17/2.8) or human (MG-63) osteosar- 
coma cell lines (Figs. 2 and 3). The two-dimensional patterns of 
nuclear matrix proteins in the osteosarcoma cells indicates at least five 
major proteins, the expression of which is either specific or signifi- 
cantly elevated. These proteins have apparent molecular weights of 
35,000--38,000 (designated 7 and 8), 72,000 (designated 3), 95,000 
(designated 2), and (designated 1). Expression of the Mr 95,000 and 
Mr 180,000 proteins s tumor specific and growth dependent, while the 
proteins designated 3, 7, and 8 are tumor specific and proliferation 
independent. 
Nuclear Matrix Proteins as Markers for Osteosarcoma. We 
have established that the representation of nuclear matrix proteins 
characterizes the osteosarcoma phenotype from three standpoints: (a) 
coexpression of nuclear matrix proteins restricted to the proliferation 
or postproliferative d velopmental stages of osteoblast differentiation; 
(b) the presence of two unique classes of nuclear matrix proteins not 
represented in normal diploid osteoblasts; and (c) an absence of 
nuclear matrix proteins found only in normal diploid osteoblasts. 
The simultaneous expression of genes in osteosarcoma cells which 
are developmentally expressed in a sequential and mutually exclusive 
manner in normal diploid osteoblasts suggests a functional relation- 
ship between tumor-related modifications in nuclear matrix proteins 
and those observed in the expression of cell growth and tissue-specific 
genes. Such a regulatory role for nuclear matrix proteins is consistent 
with the association of cell growth and bone-specific transcription 
factors with the nuclear matrix (24, 39, 40) and growth-related parti- 
tioning of oncogene-encoded transcription factors between the nuclear 
matrix and nonmatrix nuclear fraction in a proliferation-dependent 
manner (39). Involvement of the nuclear matrix in the processing of 
primary gene transcripts, and particularly the targeting of mRNAs, 
may also be important in this context (27). 
It must be acknowledged that the transcription regulatory mecha- 
nisms by which the nuclear matrix contributes to modifications in the 
extent o which proliferation and phenotypic genes are expressed in 
transformed and tumor cells remains to be determined. However, there 
is a striking representation f nuclear matrix proteins unique to cells, 
tissues, and developmental stages of differentiation and tissue orga- 
nization. Together with selective association of regulatory molecules 
with the nuclear matrix in a growth- and differentiation-specific man- 
ner there is a potential for the application of nuclear matrix proteins to 
tumor diagnosis, assessment of tumor progression, and prognosis of 
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Fig. 3. Schematic representation f nuclear matrix proteins in normal diploid osteoblasts (A), ROS 17/2.8 rat osteosarcoma cells (B), and MG-63 human osteosarcoma cells (C). 
The nuclear matrix proteins resolved in the two-dimensional gels shown in Fig. 2 are designated as follows: solid symbols (designated 4 and 5) indicate the presence of nuclear matrix 
proteins characteristic of postproliferative normal diploid osteoblasts that are coexpressed in both proliferating and postproliferative osteosarcoma cells or protein 6, which is 
proliferation independent but only observed in normal diploid cells. The tumor-specific nuclear matrix proteins are designated by stippled symbols. Unfilled symbols indicate the absence 
of designated nuclear matrix proteins. 
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